Thoracic metastasectomy for adoptive immunotherapy of melanoma: A single-institution experience

Journal of Thoracic and Cardiovascular Surgery

Volumn 140, Issue 6, 2010, Pages 1276-1282

  Klapper, Jacob A ^a   Davis, Jeremy L ^a   Ripley, R Taylor ^a   Smith, Franz O ^a   Nguyen, Dao M ^a   Kwong, King F ^a   Mercedes, Leandro ^a   Kemp, Clinton D ^a   Mathur, Aarti ^a   White, Donald E ^a   Dudley, Mark E ^a   Wunderlich, John R ^a   Rosenberg, Steven A ^a   Schrump, David S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

ACT; Adoptive cell transfer; IL 2; Interleukin 2; NED; NMA; No evaluable disease; Nonmyeloablation; TBI; TIL; Total body irradiation; Tumor infiltrating lymphocyte

Indexed keywords

ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; FLUDARABINE; INTERLEUKIN 2; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADOPTIVE IMMUNOTHERAPY; ADULT; AGED; ARTICLE; BLOOD CLOTTING DISORDER; CELL TRANSFER; DISEASE COURSE; DRUG MEGADOSE; FEBRILE NEUTROPENIA; FEMALE; HEMATOTHORAX; HUMAN; LUNG LOBECTOMY; MAJOR CLINICAL STUDY; MALE; MELANOMA; PNEUMONIA; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SURGICAL MORTALITY; SURVIVAL RATE; THORACIC METASTASECTOMY; THORACOTOMY; THORAX SURGERY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL CULTURE; VIDEO ASSISTED THORACOSCOPIC SURGERY; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MALE; MELANOMA; MIDDLE AGED; PALLIATIVE CARE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; THORACIC SURGERY, VIDEO-ASSISTED; THORACOTOMY; TREATMENT OUTCOME;

EID: 78449248952     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2010.05.020     Document Type: Article

References (25)

1. P. Ghosh, and L. Chin Genetics and genomics of melanoma Exp Rev Dermatol 4 2009 131 143
2. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and T. Murray Cancer statistics, 2008 CA Cancer J Clin 58 2008 71 96
3. A. Barth, L.A. Wanek, and D.L. Morton Prognostic factors in 1,521 melanoma patients with distant metastases J Am Coll Surg 181 1995 193 201
4. C.M. Balch, S.J. Soong, J.E. Gershenwald, J.F. Thompson, D.S. Reintgen, and N. Cascinelli Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system J Clin Oncol 19 2001 3622 3634
5. S.A. Rosenberg, J.C. Yang, D.E. White, and S.M. Steinberg Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response Ann Surg 228 1998 307 319
6. Y. Li, and E.F. McClay Systemic chemotherapy for the treatment of metastatic melanoma Semin Oncol 29 2002 413 426
7. P.B. Chapman, L.H. Einhorn, M.L. Meyers, S. Saxman, A.N. Destro, and K.S. Panageas Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma J Clin Oncol 17 1999 2745 2751
8. M.E. Dudley, J.C. Yang, R. Sherry, M.S. Hughes, R. Royal, and U. Kammula Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens J Clin Oncol 26 2008 5233 5239
9. M.E. Dudley, J.R. Wunderlich, T.E. Shelton, J. Even, and S.A. Rosenberg Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients J Immunother 26 2003 332 342
10. K.Q. Tran, J. Zhou, K.H. Durflinger, M.M. Langhan, T.E. Shelton, and J.R. Wunderlich Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy J Immunother 31 2008 742 751
11. P. Therasse, S.G. Arbuck, E.A. Eisenhauer, J. Wanders, R.S. Kaplan, and L. Rubinstein New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 2000 205 216
12. M.F. Berry, J. Hanna, B.C. Tong, W.R. Burfeind Jr., D.H. Harpole, and T.A. D'Amico Risk factors for morbidity after lobectomy for lung cancer in elderly patients Ann Thorac Surg 88 2009 1093 1099
13. K.S. Albain, R.S. Swann, V.W. Rusch, A.T. Turrisi III, F.A. Shepherd, and C. Smith Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial Lancet 374 2009 379 386
14. H. Tawbi, and N. Nimmagadda Targeted therapy in melanoma Biologics 3 2009 475 484
15. F.O. Smith, S.G. Downey, J.A. Klapper, J.C. Yang, R.M. Sherry, and R.E. Royal Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccines Clin Cancer Res 14 2008 5610 5618
16. G.Q. Phan, J.C. Yang, R.M. Sherry, P. Hwu, S.L. Topalian, and D.J. Schwartzentruber Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma Proc Natl Acad Sci U S A 100 2003 8372 8377
17. P. Attia, G.Q. Phan, A.V. Maker, M.R. Robinson, M.M. Quezado, and J.C. Yang Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4 J Clin Oncol 23 2005 6043 6053
18. S.A. Rosenberg, N.P. Restifo, J.C. Yang, R.A. Morgan, and M.E. Dudley Adoptive cell transfer: a clinical path to effective cancer immunotherapy Nat Rev Cancer 8 2008 299 308
19. L.A. Gorenstein, J.B. Putnam, G. Natarajan, C.A. Balch, and J.A. Roth Improved survival after resection of pulmonary metastases from malignant melanoma Ann Thorac Surg 52 1991 204 210
20. D.H. Harpole Jr., C.M. Johnson, W.G. Wolfe, S.L. George, and H.F. Seigler Analysis of 945 cases of pulmonary metastatic melanoma J Thorac Cardiovasc Surg 103 1992 743 750
21. R.P. Petersen, S.I. Hanish, J.C. Haney, C.C. Miller III, W.R. Burfeind Jr., and D.S. Tyler Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma J Thorac Cardiovasc Surg 133 2007 104 110
22. D.T. Alexandrescu Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages Dermatol Online J 15 2009 1
23. I. de Melo-Martin, and A. Ho Beyond informed consent: the therapeutic misconception and trust J Med Ethics 34 2008 202 205
24. W.G. Cahan Excision of melanoma metastases to lung: problems in diagnosis and management Ann Surg 178 1973 703 709
25. L. Tafra, P.S. Dale, L.A. Wanek, K.P. Ramming, and D.L. Morton Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax J Thorac Cardiovasc Surg 110 1995 119 129